Ampligen rintatolimod: Phase I/II started

Hemispherx began a double-blind, placebo-controlled, U.S. Phase I/II to compare nasal adjuvant Ampligen plus Flumist vs. Flumist alone in 72 healthy volunteers. MedImmune LLC, a subsidiary of Astra...